Kevin Hourican - CVS Corp President


USD 104.92  1.51  1.42%   

Mr. Kevin Hourican is President of CVS Pharmacy of the Company. Hourican has more than 20 years of experience in the retail industry and most recently served as Executive Vice President, Retail Pharmacy, CVS Pharmacy. During his tenure as leader of the chain retail pharmacy business, he directly managed all aspects of our retail pharmacy business and partnered on key innovations including the Script Path prescription management system, the Rx Savings Finder, medication adherence programs and home delivery. Previously, Hourican served as Senior Vice President, Operations for the East division of CVS Pharmacy, overseeing nearly 5, 000 stores and more than 110, 000 colleagues in 21 states, the District of Columbia and Puerto Rico. Prior to joining CVS Health in 2012, Hourican served in executive leadership roles at Macy and Sears Roebuck where he gained significant experience in omni channel operations and front store merchandising. He holds an undergraduate degree in Economics as well as a master degree from Pennsylvania State University.
Age: 44  President Since 2018      
401 762-2137

Kevin Hourican Latest Insider Activity

Tracking and analyzing the buying and selling activities of Kevin Hourican against CVS Corp stock is an integral part of due diligence when investing in CVS Corp. Kevin Hourican insider activity provides valuable insight into whether CVS Corp is net buyers or sellers over its current business cycle. Note, CVS Corp insiders must abide by specific rules, including filing SEC forms every time they buy or sell CVS Corp'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

CVS Corp Management Efficiency

CVS Corp has Return on Asset of 3.86 % which means that on every $100 spent on asset, it made $3.86 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 10.99 %, implying that it generated $10.99 on every 100 dollars invested. CVS Corp management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities. CVS Corp Return on Investment is relatively stable at the moment as compared to the past year. CVS Corp reported last year Return on Investment of 9.95. As of 08/18/2022, Return on Average Assets is likely to grow to 0.038, while Return on Average Equity is likely to drop 0.10. CVS Corp Revenue to Assets are relatively stable at the moment as compared to the past year. CVS Corp reported last year Revenue to Assets of 1.25. As of 08/18/2022, Total Assets Per Share is likely to grow to 190.16, while Current Assets are likely to drop slightly above 52.3 B.
The company has 75.92 B in debt with debt to equity (D/E) ratio of 1.02, which is OK given its current industry classification. CVS Corp has a current ratio of 0.86, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Debt can assist CVS Corp until it has trouble settling it off, either with new capital or with free cash flow. So, CVS Corp's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like CVS Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for CVS Corp to invest in growth at high rates of return. When we think about CVS Corp's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing few of many executives


Kay MeggersAlcoa Corp
Robert LongCoca-Cola
Richard FloerschMcDonalds Corp
Danielle MerfeldGeneral Electric
Thomas RosamiliaInternational Business Machines
Kevin OzanMcDonalds Corp
Colleen ArnoldInternational Business Machines
Elizabeth RutledgeAmerican Express
Suresh KumarWalmart
Atul SinghCoca-Cola
Nathan KalumbuCoca-Cola
Kelly JohnstoneCoca-Cola
James BushAmerican Express
Joseph MartinettoThe Charles Schwab
David FairhurstMcDonalds Corp
Rick PetrinoAmerican Express
Robert CollinsAlcoa Corp
Bruno LeoInternational Business Machines
Marc GordonAmerican Express
Robert PiccianoInternational Business Machines
Ian BordenMcDonalds Corp
CVS Health Corporation provides health services in the United States. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island. CVS Corp operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 216000 people. CVS Corp (CVS) is traded on New York Stock Exchange in USA. It is located in One CVS Drive, Woonsocket, RI 02895, United States and employs 216,000 people. CVS Corp is listed under Retail category by Fama And French industry classification.

CVS Corp Leadership Team

Elected by the shareholders, the CVS Corp's board of directors comprises two types of representatives: CVS Corp inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVS Corp. The board's role is to monitor CVS Corp's management team and ensure that shareholders' interests are well served. CVS Corp's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVS Corp's outside directors are responsible for providing unbiased perspectives on the board's policies.
Edward Ludwig, Independent Director
J Joyner, Executive Vice President
David Dorman, Independent Chairman of the Board
Shawn Guertin, Chief Financial Officer, Executive Vice President
Richard Bracken, Independent Director
Mary Schapiro, Independent Director
Richard Swift, Independent Director
Fernando Aguirre, Independent Director
Laurie Havanec, Chief People Officer, Executive Vice President
C Brown, Independent Director
NancyAnn DeParle, Independent Director
David Brown, Independent Director
JeanPierre Millon, Independent Director
Mark Bertolini, Independent Director
Alecia DeCoudreaux, Independent Director
William Weldon, Independent Director
Kevin Hourican, Executive Vice President, President of CVS Pharmacy
Stephen Gold, Senior Vice President CIO
Joshua Flum, Executive Vice President, Chief Strategy and Business Development Officer
Troyen Brennan, Executive Vice President Chief Medical Officer
Prem Shah, Executive Vice President, Chief Pharmacy Officer and Co-President of Retail
Lisa Bisaccia, Chief Human Resource Officer, Executive Vice President
David Denton, CFO and Executive VP
Karen Lynch, President, Chief Executive Officer, Director
Helena Foulkes, Executive VP and President of CVS Pharmacy Inc
Thomas Moriarty, Executive Vice President, General Counsel, Chief Policy and External Affairs Officer
Tony White, Independent Director
Anne Finucane, Independent Director
Derica Rice, Executive Vice President, President of CVS Caremark
James Clark, Senior Vice President - Controller, Chief Accounting Officer
Per Lofberg, Executive Vice President
Eva Boratto, Chief Financial Officer, Executive Vice President
David Joyner, Executive Vice President
Jonathan Roberts, Chief Operating Officer, Executive Vice President
Daniel Finke, Executive Vice President and Presidentident - Health Care Benefits Segment
Larry Merlo, President, Chief Executive Officer, Director
Alan Lotvin, Executive Vice President and Presidentident - CVS Caremark
Neela Montgomery, Executive Vice President and President - CVS Pharmacy/Retail
Roger Farah, Independent Director
Andrew Sussman, Senior Vice President Associate Chief Medical Officer
Robert Kraft, Executive Vice President
Michelle Peluso, Executive Vice President, Chief Customer Officer and Co-President of Retail

CVS Corp Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVS Corp a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in CVS Corp without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Rebalancing Now


Portfolio Rebalancing

Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
All  Next Launch Module

Pair Trading with CVS Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVS Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVS Corp will appreciate offsetting losses from the drop in the long position's value.

Moving together with CVS Corp

0.79AAgilent Technologies Upward RallyPairCorr

Moving against CVS Corp

0.77ACURAcura Pharma Cmn Earnings Call  This WeekPairCorr
0.51BZUNBaozun Inc ADR Earnings Call  This WeekPairCorr
The ability to find closely correlated positions to CVS Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVS Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVS Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVS Corp to buy it.
The correlation of CVS Corp is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVS Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVS Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVS Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Trending Equities. Note that the CVS Corp information on this page should be used as a complementary analysis to other CVS Corp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for CVS Corp Stock analysis

When running CVS Corp price analysis, check to measure CVS Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Corp is operating at the current time. Most of CVS Corp's value examination focuses on studying past and present price action to predict the probability of CVS Corp's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move CVS Corp's price. Additionally, you may evaluate how the addition of CVS Corp to your portfolios can decrease your overall portfolio volatility.
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Bond Directory
Find actively traded corporate debentures issued by US companies
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Fund Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Is CVS Corp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CVS Corp. If investors know CVS Corp will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CVS Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
139.7 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of CVS Corp is measured differently than its book value, which is the value of CVS Corp that is recorded on the company's balance sheet. Investors also form their own opinion of CVS Corp's value that differs from its market value or its book value, called intrinsic value, which is CVS Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CVS Corp's market value can be influenced by many factors that don't directly affect CVS Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CVS Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine CVS Corp value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CVS Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.